logo

For the Inventor, By the Inventor

Edmonds, WA, United States of America

Alton C Morgan, Jr

This inventor holds 9 USPTO granted patents and 4 published patent applications. Top assignees: Neorx Corporation, Receptagen Corporation, Other. Active years: 1989-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alton C Morgan, Jr. Retrieved from https://idiyas.com/inventor/alton-c-morgan-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 350(Granted Patents)


Company Filing History:

goldMedal7 out of 156 
 
Neorx Corporation
 patents
silverMedal1 out of 6 
 
Receptagen Corporation
 patents
bronzeMedal1 out of 834,570 
Other
 patents

Years Active: 1989-1997

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5688504 - Anti-receptor and growth blocking antibodies to the vitamin B.sub.12 (1997-11-18),
2. 5635180 - Alteration of pharmacokinetics of proteins by charge modification (1997-06-03),
3. 5420105 - Polymeric carriers for non-covalent drug conjugation (1995-05-30),
4. 5322678 - Alteration of pharmacokinetics of proteins by charge modification (1994-06-21),
5. 5252713 - Polymeric carriers for non-covalent drug conjugation (1993-10-12),
6. 5106951 - Antibody conjugates (1992-04-21),
7. 5034223 - Methods for improved targeting of antibody, antibody fragments, hormones (1991-07-23),
8. 4879225 - Enhanced production of antibodies utilizing insolubilized immune (1989-11-07),
9. 4822734 - Method for improving the elicitation of IgG class monoclonal antibodies (1989-04-18),

Title: Alton C Morgan, Jr: Innovator in Biomedicine

Introduction

Alton C Morgan, Jr. is a notable inventor based in Edmonds, WA (US), recognized for his contributions to biomedicine. He holds a total of 9 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest patents is the development of anti-receptor and growth blocking antibodies to the vitamin B12/transcobalamin II receptor. This invention involves agents that antagonize or modulate the receptor, leading to cellular depletion of vitamin B12, which can prevent cell division or induce apoptosis. Additionally, he has patented charge-modified conjugates that comprise a targeting protein bound to a therapeutic or diagnostic agent. This modification can alter the pharmacokinetics of proteins, resulting in either prolonged serum half-life for therapeutic purposes or reduced half-life for diagnostic imaging.

Career Highlights

Throughout his career, Alton has worked with various organizations, including Neorx Corporation. His work has significantly impacted the field of biomedicine, particularly in the development of innovative therapeutic agents.

Collaborations

Alton has collaborated with notable individuals such as Paul G Abrams and David C Anderson, contributing to the advancement of his research and inventions.

Conclusion

Alton C Morgan, Jr. exemplifies the spirit of innovation in biomedicine through his patents and collaborations. His work continues to influence the field and offers promising advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…